PUNE: Cardiovascular disease is affecting Indians at increasingly younger ages. Studies indicate that over 50 percent of coronary artery disease-related deaths in India occur in individuals under the age of 50, while nearly one in four heart attacks is reported in people younger than 40. Maharashtra has also witnessed a growing burden of heart disease among younger populations, with rising cases among men in their 30s and women between 40 and 60 years of age. Pune, too, has seen an increase in heart attack cases among teenagers and young adults under 30, a trend experts attribute to sedentary lifestyles, unhealthy dietary habits, rising stress levels, and other lifestyle-related risk factors.

As more patients undergo angioplasty and live longer after their initial treatment, cardiologists are increasingly seeing patients return years later with recurrent blockages, narrowed stents, and complex coronary artery disease. For many, treatment often means another stent, repeat interventions, or even bypass surgery. At Sahyadri Super Speciality Hospital, Deccan Gymkhana, advanced cardiac laser therapy is helping expand treatment options for such patients, offering a minimally invasive approach that can help restore blood flow, support faster recovery, and, in selected cases, avoid additional stents or bypass surgery.

The impact of the therapy is reflected in the lives of patients across age groups and life stages. A 76-year-old man was able to avoid bypass surgery after developing a severe blockage inside a previously implanted stent, allowing him to return to the comfort of everyday life. For a 21-year-old man with a complex coronary blockage, the treatment restored blood flow while avoiding additional permanent implants, helping safeguard a future filled with ambitions and milestones yet to come. Similarly, a 56-year-old man who had already survived two heart attacks underwent laser-assisted angioplasty for recurrent blockages, enabling him to move forward without the burden of another major cardiac procedure. While their journeys were different, the outcome was the same—a renewed chance at life, health, and hope.

Advanced cardiac laser therapy is very helpful for treating stents that didn’t work, complicated blockages, and arteries with a lot of calcium, using a method that doesn’t require big cuts, and most patients go home within 24 hours.

Speaking about the growing role of technology, Dr. Abhijeet Palshikar, Director – Cardiology, Sahyadri Super Speciality Hospital, said, “As more patients undergo angioplasty and live longer after their initial treatment, we are witnessing a rise in complex coronary artery disease requiring repeat intervention. Advanced cardiac laser technology has significantly strengthened our ability to manage these challenging cases with greater precision. We are increasingly utilising this technique for specialised redo angioplasties where previously implanted stents have failed, enabling effective treatment while helping many patients avoid bypass surgery.”

Dr. Nilesh Singh, Hospital Director, Sahyadri Super Speciality Hospital, Deccan Gymkhana, “The introduction and use of advanced cardiac laser technology reflect our focus on expanding access to contemporary cardiovascular care for patients. This approach has supported the management of complex coronary conditions through a minimally invasive method. Such innovations contribute to improved clinical outcomes and patient experience, while helping reduce the need for repeat interventions in suitable cases. Over time, this has also supported the care of many patients across different clinical profiles.”

For patients living with failed stents, recurrent blockages, and complex coronary artery disease, advanced cardiac laser therapy is offering more than an alternative treatment option—it is helping many return to their families, careers, and everyday lives with renewed confidence and hope.

The post Laser Interventions in Cardiac Care: Offering New Hope When Stents Are No Longer Effective appeared first on NRI News.

Modern joint replacement is now changing this experience. At Inamdar Multispeciality Hospital, Pune, robotic joint replacement, advanced pain-control methods, and early rehabilitation protocols are helping many patients stand and walk within 24 to 48 hours after surgery.

Dr. Qaedjohar Dhariwal, Joint Replacement Surgeon at Inamdar Multispeciality Hospital, said the aim is not merely to replace a damaged joint, but to restore safe movement with minimum pain and faster confidence.

Robotic surgery does not mean that a robot operates alone. The surgeon remains fully in control. The robotic system acts as a precision-assistance platform. Before and during surgery, it helps map the patient’s joint anatomy, plan the implant position, calculate alignment, and guide accurate bone preparation. This is especially important in knee replacement because even small errors in alignment or soft-tissue balance can affect comfort, walking pattern, and implant life.

In conventional surgery, the surgeon depends heavily on visual judgment, manual instruments, and experience. In robotic-assisted surgery, the surgeon’s experience is supported by computer-guided planning and real-time feedback. This helps in achieving more accurate implant placement, better ligament balance, and a more natural-feeling joint movement.

For geriatric patients, this accuracy matters even more. Elderly patients may have weak bones, long-standing deformity, reduced muscle strength, diabetes, heart disease, or other age-related conditions. A technically precise surgery can reduce unnecessary tissue handling, help control bleeding, and support faster rehabilitation.

The second major change is pain management. Earlier, many patients feared joint replacement because the first few days after surgery were painful. Today, anaesthesia and pain-control science have improved significantly. Motor-sparing nerve blocks, local anaesthetic infiltration around the joint, and multimodal medicines can reduce pain without completely weakening the leg muscles. This allows patients to begin standing and walking under supervision much earlier.

This is why the phrase “painless surgery” must be understood correctly. Major joint replacement is still major surgery. But with robotic precision, careful anaesthesia and structured physiotherapy, the pain can be controlled far better than before. The patient is not simply lying in bed after surgery; the patient is encouraged to move safely.

Early mobilisation is one of the most important parts of recovery. Walking within 24 to 48 hours can reduce stiffness, improve circulation, lower the risk of clots, protect lung function, and rebuild confidence. For elderly patients, avoiding prolonged bed rest is critical because immobility can quickly lead to weakness, confusion, dependency, and fear of movement.

“At Inamdar Hospital, our focus is on making major joint replacement safer, more accurate, and more recoverable for the patient,” said Dr. Dhariwal. “When robotic planning, pain-control protocols, and physiotherapy work together, many senior patients are surprised to see how soon they can stand and walk again.”

For families, this progress is deeply emotional. It may mean seeing a parent walk to the dining table, climb a few steps, attend a family function or return to daily routines without constant fear.

Robotics has not made surgery casual. It has made precision measurable. For senior citizens living with advanced arthritis, that precision can mean reduced pain, faster mobility, and a smoother return to dignity, independence, and normal life.

The post The Role of Robotics in Helping Seniors Walk Again After Joint Surgery appeared first on NRI News.

Digestive health issues are frequently ignored despite presenting early warning signs such as recurring acidity, persistent bloating, unexplained stomach pain, bowel changes, fatigue, and fluctuations in weight or appetite. Recognising these symptoms and seeking timely consultation can play a crucial role in preventing more serious health complications.

Dr. Khurshed Vazifdar adds, “Digestive symptoms are often dismissed as minor or temporary, but they can sometimes indicate underlying conditions that require timely attention. Early diagnosis and intervention can significantly improve outcomes and prevent complications. We encourage individuals to listen to their bodies and seek medical advice if symptoms persist.”

Holy Family Hospital offers specialized gastroenterology, liver, and pancreas clinics, all under one roof, ensuring seamless and integrated care for patients. From everyday digestive concerns to complex liver and pancreatic disorders, the hospital’s team of experienced doctors delivers advanced, patient-focused treatment tailored to individual needs.

Their advanced care procedures include: UGI Endoscopy, Colonoscopy, ERCP, FibroScan, Endoscopic Ultrasound (EUS), and Therapeutic Endoscopy. These minimally invasive procedures enable accurate diagnosis and effective treatment of conditions such as ulcers, reflux disorders, liver fibrosis, cirrhosis, biliary tract diseases, and pancreatic disorders.

Holy Family Hospital’s Endoscopy Department is accredited by CAHO (Consortium of Accredited Healthcare Organizations), reflecting its commitment to maintaining high standards of safety, quality, and clinical excellence.

With a team of highly experienced specialists and a strong focus on patient well-being, Holy Family Hospital continues to be a trusted destination for advanced digestive care in Mumbai. 

Services Offered:

• Outpatient and diagnostic services, including FibroScan
• 24×7 Emergency Gastroenterology services
• Endoscopy services, including upper GI endoscopy and colonoscopy
• Hepatology services for liver-related conditions
• Treatment for Pancreatico-Biliary disorders
• Day-care endoscopic procedures and minor GI procedures
• Multidisciplinary care involving coordination with surgery, radiology, pathology, oncology, and dietetics. 

The post Dr. Khurshed Vazifdar Emphasizes the Significance of Digestive Health Awareness on World Digestive Health Day appeared first on NRI News.

The core leadership team includes Dr. Ketan Deshpande (Secretary General), Dr. Amol Rege (Vice President), and Kolkatta-based spine surgeon Dr. Anindya Basu as Treasurer. A comprehensive organizational structure has been established, comprising executive, scientific, and academic committees with around 30 executive members representing institutions across the country.

Unilateral bi-portal endoscopic (UBE) spine surgery is an advanced minimally invasive procedure that uses two small portals—one for a high-definition endoscopic camera and the other for surgical instruments—to access the spine with precision. This endoscopic approach allows surgeons to operate through tiny incisions while continuously visualizing the surgical field on a screen, thereby minimizing damage to surrounding muscles, ligaments, and tissues. Unlike traditional open surgery, it avoids large cuts and extensive dissection, resulting in less blood loss, reduced post-operative pain, and faster recovery, said Dr Amol Rege. UBE can be effectively used across the entire spine, including cervical (neck), thoracic (mid-back), and lumbar (lower back) regions. It is commonly indicated for conditions such as slipped discs, spinal stenosis, nerve compression, infections, and even certain fusion procedures, added Dr Ketan Deshpande. Dr Anindya Basu said that the technique combines the advantages of endoscopy with the flexibility of conventional instruments, making it a versatile and increasingly preferred option in modern spine care. The procedure has been developed in Korea over the past decade and widely adopted globally. Its cost-effectiveness and adaptability make it suitable even for smaller hospitals.

Dr. Shailesh Hadgaonkar said that this is an important milestone in the field of spine surgeries in India. The India Chapter aims to create structured academic programs, standardized training modules, and fellowship opportunities to ensure safe and effective adoption of this technique. With approximately 9-10 thousand spine surgeons in India, the initiative targets both young and experienced neurosurgeons and orthopaedic spine specialists who are increasingly transitioning toward endoscopic approaches.

The official installation ceremony of the India Chapter will be held on June 20–21, 2026, bringing together leading spine surgeons from across the country for the first in-person gathering following initial virtual meetings conducted in recent weeks.
Dr.Hadgaonkar said that the India Chapter will be aligned with global UBE chapters in the United States, Australia, China, and Korea and will facilitate international collaboration, workshops, and knowledge exchange—advancing the future of minimally invasive spine surgery in the region.

The post Historic Launch of Indian Subcontinent Chapter by World UBE Spine Society appeared first on NRI News.

HYDERABAD: For nearly five months, a 14-year-old boy from Hayathnagar lived through a nightmare that neither he nor his family could understand. What began as repeated vomiting slowly turned into constant suffering, severe weakness, inability to eat properly, and, later, even constipation. Hospital after hospital, test after test, and multiple medications brought no answers and no relief.

As the young boy’s health continued to deteriorate, frustration and fear gripped the family. Despite several consultations and investigations at different hospitals, doctors were unable to identify the exact cause behind his worsening condition.

Hope finally emerged when the family reached out to Dr. Bhupathi Rajendra Prasad, Sr. Consultant & Head, Department of Surgical Gastroenterology & Robotic Surgery at CARE Hospitals, Malakpet, through contacts in their local colony.

During the very first consultation, after carefully listening to the patient’s history and symptoms, Dr. Bhupathi suspected a rare and often-missed condition called Superior Mesenteric Artery (SMA) Syndrome— a disorder in which part of the small intestine gets compressed between major blood vessels, leading to persistent vomiting, abdominal pain, nutritional deficiency, and severe digestive problems.

To confirm the diagnosis, the patient underwent a Contrast-Enhanced CT (CECT) Abdomen scan at a reputed diagnostic centre in Hyderabad. Surprisingly, the initial report described the scan as normal, despite the suspected diagnosis being specifically mentioned in the clinical notes.

But Dr. Bhupathi was not convinced.

After personally reviewing the CT films and discussing the case in detail with radiologists using the scan CD, his suspicion remained strong. He advised a repeat evaluation, which finally confirmed the rare SMA Syndrome diagnosis, solving the mystery that had troubled the family for months.

Soon after, the teenager underwent a successful Laparoscopic Duodenojejunostomy, an advanced minimally invasive surgery performed to bypass the compressed portion of the intestine. The surgery was successful, and the boy was discharged within just three days.

Today, the teenager is completely symptom-free, eating normally, and has returned to his routine life.

Speaking about the case, Dr. Bhupathi Rajendra Prasad said, “This was not just about treating a disease, but about identifying a condition that many may overlook because the symptoms resemble common gastric problems. In patients with persistent unresolved symptoms, doctors must think beyond routine diagnoses. Careful clinical judgement and correlation with imaging are extremely important in arriving at the correct diagnosis.”

Dr. Praveen Kumar Edla, Chief Operating Officer, CARE Hospitals, Malakpet, said, “This case highlights the importance of expertise, persistence, and multidisciplinary teamwork in solving complex medical conditions. At CARE Hospitals, we are committed to delivering advanced and patient-centric care, especially in rare and challenging cases where timely diagnosis can completely change a patient’s life.”

Doctors say SMA Syndrome is considered a rare gastrointestinal disorder and is often difficult to diagnose because its symptoms mimic common digestive illnesses. Specialists caution that persistent vomiting, unexplained abdominal discomfort, sudden weight loss, and prolonged digestive complaints should never be ignored, especially when symptoms continue despite repeated treatment.

For this Hyderabad family, what once felt like an endless medical struggle has now become a story of recovery, hope, and a second chance at normal life.

The post Hyderabad Teen’s Battle with a Mysterious Illness appeared first on NRI News.

INDIA: Dr. Reddy’s and Nestlé Health Science Limited, a joint venture between Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Nestlé India Limited (BSE: 500790, NSE: NESTLEIND) referred hereafter as “Nestlé India”, today announced the launch of Celevida^®GLP+, a specialised scientifically designed product to support optimum nutrition intake and muscle mass maintenance for sustaining metabolic and functional health for people undergoing GLP-1/GIP therapy* for management of type 2 diabetes and obesity in India.

As GLP-1/GIP–based therapies become more widely adopted in the management of type 2 diabetes and obesity, improving access to advanced treatment options for patients, it has become increasingly important to build an integrated ecosystem beyond medication. Encompassing nutrition, clinical monitoring, and long-term patient support, this ecosystem should be an enabler for sustained and holistic outcomes for patients managing type 2 diabetes and obesity. A critical component of this approach is addressing the nutritional gaps and muscle health challenges associated with these therapies to improve overall outcomes.

M.V. Ramana, CEO, Global Generics at Dr. Reddy’s Laboratories Limited and Director, Dr. Reddy’s and Nestlé Health Science Limited, “GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy. As patients experience changes in body composition, ensuring adequate nutrient intake and maintaining lean body mass become critical to sustaining long-term outcomes. With Celevida^® GLP+, we aim to address this gap through a targeted, science-backed nutritional solution that complements pharmacological therapies and supports better overall patient outcomes in their everyday journey. As part of this commitment, we remain focused on advancing integrated, patient-centric solutions that enable more sustainable and holistic management of metabolic health.”

Insights from senior Indian clinicians highlighted a critical and often under-recognized risk: muscle loss during GLP-1/GIP therapy. Studies indicate that 25-40% of total weight loss associated with GLP-1 and dual GLP-1/GIP therapies may be attributed to lean body mass loss ^(1,2). Experts noted that this risk may be amplified in Indians due to inherently lower baseline skeletal muscle mass and higher body fat mass (3), which may be further compounded by chronically low protein intake of approximately 0.6g/kg/day⁽⁴⁾. This creates a dual vulnerability, making muscle preservation not just important, but essential for long-term metabolic health.

Clinical and expert consensus recommend increasing protein intake to 1.2–1.5 g/kg/day to help preserve muscle mass during weight loss, highlighting the need for customised nutritional support ⁽⁵⁾.

Addressing this need, Celevida^® GLP+ has been scientifically designed and co-created with leading endocrinologists and diabetologists to address protein gaps and preserve muscle mass and function in individuals undergoing GLP-1/GIP therapy. It is formulated using fast-absorbing whey protein isolate (WPI), known to be gentle on the gut and suitable during periods of gastrointestinal intolerance commonly associated with GLP-1/GIP therapy.  Celevida® GLP+ provides 48 g of protein per 100 g, along with 100% RDA (Recommended Dietary Allowance) of branched-chain amino acids (BCAAs). It also provides 27 essential nutrients, including vitamins A, D, and calcium. Dr. Reddy’s and Nestlé Health Science have an established presence in specialised nutrition for people with diabetes through its Celevida^® Diabetes Nutrition, designed to support comprehensive diabetes management. The formulation is clinically proven to support sustained 24-hour blood glucose control and reduce HbA1c levels (6), and is characterised by a low glycaemic index⁽⁷⁾, making it suitable for long-term metabolic management.

Celevida^® GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms.

The post Dr. Reddy’s and Nestlé Health Science Collaborate to Launch Celevida® GLP+ appeared first on NRI News.

BENGALURU: Taking a major initiative towards expert liver care, Aster Whitefield Hospital has declared the launch of the first dedicated Liver Intensive Care Unit (ICU) in Karnataka. This is a state-of-the-art facility designed only for liver failure patients, those having biliary problems, and liver transplant cases. The ICU, named SHIELD (Specialized Hepatic Intensive & Emergency Liver Division), is a state-of-the-art facility designed solely for patients with liver failure, biliary problems, and liver transplant cases. Setting the Liver-specific ICU as a real rescue for patients in critical condition, it is a confluence of renowned doctors, modern facilities, and continuous patient monitoring to provide highly specialised, multi-disciplinary care aimed at improving patient outcomes. Through this, Aster has once again shown its desire to promote islands of excellence aimed at quaternary single-organ care pathways for better results for patients with complicated liver diseases. The programme was honoured by the presence of Dr. C. N. Manjunath, Hon’ble Member of Parliament (Lok Sabha), as the Chief Guest.

Speaking ahead of the inauguration, Dr. C. N. Manjunath said, “Liver problems are turning out to be a sneaky but major health issue in India, and usually, it’s at a very severe stage when the patients are found. A liver ICU dedicated to liver care opening at Aster Whitefield Hospital is a very appropriate and great step that will enable our healthcare system to be more efficient and quicker in handling very difficult liver cases. Apart from better survival chances, specialized facilities equip the patient care to be comprehensive and in collaboration with various medical disciplines.”

Adding to this, Dr. H R S Girn, Senior Consultant – HPB and Liver Transplant surgeon, Aster Whitefield Hospital, said: “The establishment of a specialty Liver ICU represents an innovative approach in the establishment of a single point care facility for liver sick patients requiring what we call the Liver Arc services (Hepatology, ICU, Surgery, Transplantation, Luminal and radiological interventions) under one roof. A person with decompensated cirrhosis or liver failure experiences rapid changes within a short period of time. Thus, in this case, having a speciality dedicated ICU implies that all actions can be taken efficiently and effectively for the patients and their families. In turn, this provides a seamless referral and healthcare delivery pathway aimed at holistic liver care, liver-specific training for budding future specialists, and brings liver care at par with other resource-intensive single-organ dedicated ICUs like the Cardiac or Neuro ICUs, which have traditionally been the norm.  With busy lives, nuclear families, and increasing liver disease burden in the country, single organ-specific facilities under trusted brands like Aster are the need of the hour as a single point of contact resource for the patients suffering from life-threatening conditions.”

Srikant Subudhi, Chief Operating Officer, Aster Whitefield Hospital, added: “At Aster Whitefield Hospital, the core of our efforts is the creation of highly sophisticated, patient-oriented healthcare ecosystems that can effectively meet the various clinical needs of today and tomorrow. The launching of Karnataka’s first dedicated Liver ICU is a powerful indication of how we are always ready to put our money into the specialised infrastructure which is capable of dealing with the increasing complexity of liver-related diseases. Not only does this facility leverage state-of-the-art technology and a wide range of medical experts, but it also ensures continuous monitoring for better clinical results and provides easier access to specialised and high-quality treatment.“

The Liver ICU will be a collaborative endeavor by a team of highly skilled and proficient physicians, including liver transplantation surgeons, hepatologists, and gastroenterologists, as well as critical care specialists. This dedicated unit will try to fill a major void in the liver care infrastructure of Karnataka, and it will be a one-stop solution for patients to get timely, cutting-edge, and life-saving treatment.

The post Aster Whitefield Hospital Unveils Karnataka’s First Dedicated Liver ICU appeared first on NRI News.

The patient was admitted to the Critical Care Unit (CCU) at Inamdar Multispeciality Hospital on 1/3/26 under Dr. Amit Mazumdar with a sudden onset of breathlessness and severe oxygen desaturation following the consumption of outside food. She was a high-risk case, with multiple co-morbidities including morbid obesity, diabetes, and multinodular toxic goiter, and was also diagnosed with pneumothorax.

Initial Management (Date: 4/3/26)

An intercostal drainage (ICD) tube was inserted to manage the pneumothorax. The patient was stabilised and maintained on ventilatory support, with a trial on T-piece conducted after initial improvement.

Failed Extubation Attempts (Dates: 5/3/26 / __)

Despite meeting extubation parameters, two separate attempts to wean her off ventilatory support failed due to persistent desaturation, necessitating re-intubation. The inability to sustain spontaneous breathing raised the need for a definitive airway solution.

At this stage, the treating team explained the need for tracheostomy and thyroidectomy to the family. Given the perceived risks associated with thyroid surgery, the relatives initially consented only to tracheostomy, which was considered semi-urgent.

Intraoperative Turning Point (Date of Surgery: 9/3/26)

During surgery at Inamdar Multispeciality Hospital, doctors encountered a critical anatomical challenge. The patient had a massively enlarged thyroid gland extending retrosternally and completely engulfing the trachea, making tracheostomy technically impossible without first removing the thyroid.

This intraoperative finding necessitated an immediate change in surgical plan. The patient’s relatives were counselled again in real time regarding the urgency and inevitability of proceeding with thyroidectomy.

The surgery was led by Dr. Pravin Bhosale, ENT Surgeon, with support from the general surgery team—Dr. Nelson and Dr. Abhijeet Gotkhinde, while the anaesthesia team comprising Dr. Sandeep Patil and Dr. Jyoti Sawant ensured stable intraoperative management.

Following thyroid removal, the team conducted critical intraoperative assessments. The integrity of both recurrent laryngeal nerves was confirmed, the parathyroid glands were preserved, and there was no evidence of tracheomalacia.

Critical Surgical Decision

Based on these findings, the team made a decisive call to avoid tracheostomy and attempt controlled extubation.

Dr. Pravin Bhosale, ENT Surgeon, said, “This was a highly critical case because what appeared to be a routine need for tracheostomy turned into a complex airway emergency inside the operating theatre. The thyroid was massively enlarged and retrosternal, completely engulfing the trachea, leaving no safe option except to change the surgical plan immediately. In such situations, precise judgment, timing, and coordinated teamwork are absolutely crucial to achieving a successful outcome.”

Post-Operative Recovery (Date: 10/3/26)

The patient’s recovery was notably rapid. She required only two days of CCU care post-surgery. Swallowing function was assessed using bedside FEES (Functional Endoscopic Evaluation of Swallowing), following which all supportive lines and tubes, including Ryle’s tube, catheter, and surgical drains, were removed in a phased manner.

Discharge and Outcome (Date of Discharge: 14/3/26)

The patient was discharged in stable condition, marking a successful outcome in what doctors at Inamdar Multispeciality Hospital describe as a rare convergence of airway compromise and endocrine pathology.

Reflecting on her experience, the patient said, “I was struggling to breathe, and it was a very difficult time for my family and me. The doctors explained every step and gave us confidence throughout. I feel grateful to have recovered and to be going home.”

The case involved a multidisciplinary effort, with contributions from Dr. Mulla (Endocrinologist), Dr. Ajinkya Gulave, and Dr. Vrushali (Pulmonologists), along with ICU teams, operation theatre staff, and hospital support departments.

Clinical Significance

Doctors involved in the case emphasised that such outcomes depend heavily on real-time intraoperative judgment, multidisciplinary coordination, and the ability to adapt surgical strategy based on evolving clinical findings.

The post A High-Risk Thyroid Case and the Impact of Airway Access Failure on Surgical Decisions appeared first on NRI News.

As part of the camp, Shanti Clinic will offer an all-inclusive cataract surgery package at ₹9,999. The package is designed to provide transparent, accessible, and high-quality care to a wider group of patients. The surgery is performed by experienced surgeons, using advanced equipment and high-quality intraocular lenses (IOLs).

Individuals experiencing symptoms such as blurred vision, glare, or difficulty in daily activities are encouraged to visit during the camp period for screening and guidance on treatment options.

Shanti Clinic is a diagnostic and healthcare centre operated by the Sadhu Vaswani Mission. The clinic offers consultations, diagnostic services, and an in-house optical shop, Bright Eyes.

For registrations, please contact: Dr Pooja Patel, Counsellor on 9168013322.

Address: Shanti Clinic 9, Sadhu Vaswani Rd, opposite Sadhu Vaswani Mission, Agarkar Nagar, Pune 411001.

Clinic timings: 9.30 am to 6.30 pm.

The post Shanti Clinic Launches Affordable Cataract Camp appeared first on NRI News.

The initiative comes at a time when obesity is increasingly recognized as a medical condition rather than merely a lifestyle issue. Recently, obesity has been formally classified as a disease in international medical coding systems (ICD), enabling structured treatment approaches including medical therapies and advanced bariatric procedures.

Mr.Naval Kishor Ram, Commissioner, Pune Municipal Corporation, said that there is a lack of awareness about Non-Communicable Diseases (NCDs)  in people. We inculcate the importance of early and proper diagnosis. Commending the initiative, he said that through this centre, Noble Hospital has taken a very important step to address the very root of obesity.

One of its kind, an integrated and comprehensive centre for obesity 

This is one of its kind centres for the management of obesity with a holistic approach through integrated and comprehensive care for all kinds of obesity for adults as well as small children. Individuals seeking medical advice for obesity are guided by an obesity management group comprising a multidisciplinary team, right from a physician to a surgeon to a psychologist, delivering world-class non-surgical as well as surgical treatment regulated by international standards.

The new centre will offer integrated care through a multidisciplinary team, including bariatric medicine physicians, bariatric surgeon specialists, cosmetic-plastic surgeons, obesity and metabolic health nutritionists, bariatric physiotherapists, obesity educators, and dedicated counsellors. 

The facility will provide advanced diagnostic and therapeutic options such as advanced body composition analysis, DEXA scan unit, modern bariatric surgery infrastructure like robotics, and Non-invasive weight-loss procedures like the Allurion endoscopic gastric balloon.

Being the pioneers in novel injectable medical therapies for weight loss, the hospital will integrate its experienced Bariatric physician team in this center of excellence.

To complete the transformation process, body contouring, including suitable surgical or non-surgical procedures designed to remove excess, sagging skin and stubborn fat deposits following weight loss, will also be available under one roof. The facility will also house an advanced bariatric operating table for enhanced patient safety.

The multidisciplinary team includes Dr. Reema Kashiva, Bariatric Physician, Dr. Parmeshwar Bambrule, Bariatric Surgeon, Dr. Ravi Swaminathan, Plastic Surgeon, Dr. Sarika Satav, Bariatric Clinical Nutritionist, Dt. Akshay Pawar, Dietician, Dr. Reshma Kangude-Lifestyle Educator, Dr. Bhupendra Gupta, Physiotherapist, Dr.Suhas Khaire, Endocrinologist, and Dr. Sheetal Harpale, Clinical Psychologist.

Dr. Reema Kashiva, Programme Director – Centre of Excellence for Obesity, Metabolic Diseases and Advanced Bariatric Sciences at Noble Hospitals, said that untreated obesity is associated with a lot of health complications, including diabetes, hypertension, heart disease, metabolic disorders, and many other diseases. Early and scientific intervention can significantly reduce these risks and improve quality of life.

Obesity needs to be addressed at its roots, with scientific management at each stage

According to the team at the centre, “For years, we were treating the complications of obesity rather than the disease itself. With the recognition of obesity as a medical condition and the availability of effective therapies, it is now possible to intervene early and prevent associated complications. People need guidance at every stage of weight management. Scientific, supervised, and team-based management of obesity is the need of the hour.”

While people have apprehensions about the side effects of medications, most of these can be tackled when taken under medical supervision. What should be considered is the risk of having weight versus the benefit of using injectable medicines to reduce weight and live a better quality of life in the future, and aiming to reduce the future complications of obesity.

The centre aims to create greater public awareness about obesity as a treatable disease and create awareness amongst people with a BMI above 30, or above 27 with comorbid conditions, to seek timely medical consultation.

Dr. Sanjay Pathare, Group Executive Officer, Noble Hospitals and Research Center, said that  “Obesity today is increasingly driven by poor dietary habits, over-nutrition, sedentary lifestyles, and stress, not just in adults but also in small children, and early and effective obesity management can significantly reduce the risk of multiple chronic diseases.“

Dr. Divij Mane, Deputy  Managing Director, Noble Hospitals, said, “Not every obese patient needs surgery. In a center of excellence, precise BMI, BCA, and comorbidity assessment is done. Non-surgical options are primarily considered. Risks such as Type 2 Diabetes, Obstructive Sleep Apnea, hypertension, and heart disease are proactively evaluated, and appropriate treatment is made available under one roof. We aim to ensure the right care plan from the right team of experts reaches every individual, from the treatment phase to follow-up care to ensure long-term well-being.”

With this integrated super-specialist team approach, Noble Hospitals seeks to strengthen its commitment to advanced metabolic care and preventive healthcare for patients in Pune and across the region.

Dr. Dileep Mane, Chairman and Managing Director, Noble Hospitals, said that “Obesity is a complex, multi-faceted disease; hence, instead of multiple standalone consults, when a dedicated team of experts jointly provides an integrated care plan tailored to each individual’s needs, you get effective and more sustainable outcomes.“

Through this Centre for Obesity, Metabolic Diseases and Advanced Bariatric Sciences, we aim to redefine obesity care with integrated treatment, advanced technology, and sustained patient support

The post Noble Hospital Unveils Centre of Excellence for Obesity and Metabolic Diseases appeared first on NRI News.